Concepedia

Publication | Open Access

Rates of Serious Infections and Malignancies Among Patients with Rheumatoid Arthritis Receiving Either Tumor Necrosis Factor Inhibitor or Rituximab Therapy

DOIFull Paper Access

78

Citations

16

References

2015

Year

Kalle Aaltonen, J. Joensuu, Liisa Virkki, Tuulikki Sokka, Pasi Aronen, Heikki Relas, Heikki Valleala, Vappu Rantalaiho, Laura Pirilä, Kari Puolakka,
The Journal of Rheumatology

Abstract

Our results provide some reassurance of the safety of biologic treatments in the treatment of RA.

References

YearCitations

Page 1